| Literature DB >> 32741477 |
Abstract
The 2017 (fourth edition) World Health Organization Classification of Endocrine Tumors has recommended major changes in classification of tumors of the pituitary gland and region. In addition to the accurate tumor subtyping, assessment of the tumor proliferative potential (mitotic and/or Ki-67 index) and other clinical parameters such as tumor invasion is strongly recommended in individual cases for consideration of clinically aggressive adenomas. It is expected that this new WHO classification will establish more uniform biologically and clinically groups of pituitary tumors and contribute to understanding of clinical outcomes for patients harboring pituitary tumors.Entities:
Keywords: Immunohistochemistry; Pituitary adenoma; Pituitary gland; Pituitary neuroendocrine tumor
Mesh:
Year: 2020 PMID: 32741477 DOI: 10.1016/j.ecl.2020.05.001
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741